Insider trades
Rahul D. Ballal, Director of Agios Pharmaceuticals AGIO, has filed 0 purchases and 15 sales on the open market. The latest trade was on 06/18.
Rahul D. Ballal
Director
- Company
- Agios Pharmaceuticals AGIO
- First filing
- 23/02/01
- Trades
- 62 trades
- Buys / sales
- 0 / 15
- 12-month net buying
- No record
- Last trade
- 06/18
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
AGIO | Open-market sale10b5-1 plan | 24/11/07–24/11/08 | 24/11/12 | 20,000 sh5 trades | $55.86avg. | $1,117,146.69 | −71.4% |
| Open-market sale10b5-1 plan | 24/10/08 | 24/10/10 | 10,420 sh | $28.17 | $293,531.4 | −31.8% | |
ELVN | Open-market sale10b5-1 plan | 24/04/10–24/04/11 | 24/04/12 | 67,000 sh4 trades | $23.36avg. | $1,565,022.28 | −75.0% |
| Open-market sale10b5-1 plan | 24/04/04 | 24/04/08 | 3,485 sh | $19.15 | $66,737.75 | −13.5% | |
| Open-market sale10b5-1 plan | 24/04/01 | 24/04/03 | 3,237 sh | $19.08 | $61,761.96 | −12.7% | |
| Open-market sale10b5-1 plan | 24/03/20 | 24/03/22 | 13,278 sh | $19.16 | $254,406.48 | −37.3% | |
| Open-market sale | 23/02/22 | 23/02/22 | 32,861 sh | $4.66 | $153,132.26 | −27.2% | |
| Open-market sale | 23/01/30 | 23/02/01 | 11,313 sh | $3.91 | $44,233.83 | −8.6% |
